(Q83971377)
Statements
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial (English)
Fiorentini G
Rossi S
Lanzanova G
Biancalani M
Palomba A
Bernardeschi P
Dentico P